THE INTRADAY

DHR · Company KPIs

Danaher (DHR) KPIs

Core sales growth (non-GAAP), Core sales growth excluding respiratory testing (non-GAAP). As reported in SEC filings, with the source line for each figure.

Core sales growth (non-GAAP)

3% for the period ended Sep 25, 2026

Jun 27, 2025: 1.5%Sep 26, 2025: 3%Dec 31, 2025: 2.5%Mar 27, 2026: 0.5%Jun 26, 2026: 3%Sep 25, 2026: 3%Jun 27, 2025Sep 25, 2026

The filings read for this page do not define this measure.

Core sales growth (non-GAAP), as first reported, with the line it was read from
Period endedFigureFiling text
Sep 25, 20263%Core sales growth (non-GAAP) · 3.0% · 2.0%10-Q filed 2026-10-21
Jun 26, 20263%Core sales growth (non-GAAP) · 3.0% · 2.0%10-Q filed 2026-07-21
Mar 27, 20260.5%Core sales growth (decline) (non-GAAP) · 0.5% · 7.0% · 0.5% · (4.0)%8-K filed 2026-04-21
Dec 31, 20252.5%Core sales growth (non-GAAP) · 2.5% · 6.0% · 0.5% · 2.0%8-K filed 2026-01-28
Sep 26, 20253%Core sales growth (non-GAAP) · —% · 1.5% · 3.0% · 2.5% · 2.0% · 0.5%8-K filed 2026-07-21
Jun 27, 20251.5%Core sales growth (non-GAAP) · —% · 1.5% · 3.0% · 2.5% · 2.0% · 0.5%8-K filed 2026-07-21
Mar 28, 2025—%As the company words itCore sales growth (non-GAAP) · —% · 1.5% · 3.0% · 2.5% · 2.0% · 0.5%8-K filed 2026-07-21

Core sales growth excluding respiratory testing (non-GAAP)

5.5% for the period ended Sep 25, 2026

Mar 28, 2025: 1%Jun 27, 2025: 2%Sep 26, 2025: 2.5%Dec 31, 2025: 4%Mar 27, 2026: 3%Jun 26, 2026: 4.5%Sep 25, 2026: 5.5%Mar 28, 2025Sep 25, 2026

The filings read for this page do not define this measure.

Core sales growth excluding respiratory testing (non-GAAP), as first reported, with the line it was read from
Period endedFigureFiling text
Sep 25, 20265.5%Core sales growth excluding respiratory testing (non-GAAP) · 5.5% · 4.5%10-Q filed 2026-10-21
Jun 26, 20264.5%Core sales growth excluding respiratory testing (non-GAAP) · 4.5% · 4.0%10-Q filed 2026-07-21
Mar 27, 20263%Core sales growth excluding respiratory testing (non-GAAP) · 1.0% · 2.0% · 2.5% · 4.0% · 2.5% · 3.0%8-K filed 2026-07-21
Dec 31, 20254%Core sales growth excluding respiratory testing (non-GAAP) · 1.0% · 2.0% · 2.5% · 4.0% · 2.5% · 3.0%8-K filed 2026-07-21
Sep 26, 20252.5%Core sales growth excluding respiratory testing (non-GAAP) · 1.0% · 2.0% · 2.5% · 4.0% · 2.5% · 3.0%8-K filed 2026-07-21
Jun 27, 20252%Core sales growth excluding respiratory testing (non-GAAP) · 1.0% · 2.0% · 2.5% · 4.0% · 2.5% · 3.0%8-K filed 2026-07-21
Mar 28, 20251%Core sales growth excluding respiratory testing (non-GAAP) · 1.0% · 2.0% · 2.5% · 4.0% · 2.5% · 3.0%8-K filed 2026-07-21

Reading notes

Figures are shown as first reported. If a later filing prints a different figure for the same period, both appear. A figure marked ≈ or shown in words is how the company itself states it, not an estimate of ours. Companies change definitions over time, so compare periods with the quoted definition in mind. Periods that failed our checks are left out, so gaps are expected.